Syncope clinical trials

Explore recruiting syncope clinical trials.

Recruiting syncope studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Syncope trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Randomised, open-label and parallel group trial to investigate the effects of oral BI 685509 alone or in combination with empagliflozin on portal hypertension after 8 weeks treatment in patients with clinically significant portal hypertension (CSPH) in compensated cirrhosis

Spain, Austria, Netherlands, Germany, Denmark, France +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Randomised, double-blind, placebo-controlled and parallel group trial to investigate the effects of one dose (up-titration to a fixed dose regimen) of oral BI 685509 on portal hypertension after 8 weeks treatment in patients with clinically significant portal hypertension (CSPH) in decompensated cirrhosis after their first decompensation event, who are stabilized CTP 5-7

Spain, Romania, Germany, France, Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

BONFIRE - Beta-blockers discontinuation in patients presenting heart failure with recovered left ventricular ejection fraction

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

An Investigator-Initiated Prospective Randomized Open-Label Blinded-Endpoint Crossover Trial Comparing the Effect and Safety of Flecainide and Metoprolol versus Metoprolol Alone to Suppress Ventricular Arrhythmias in Arrhythmic Mitral Valve Prolapse (FLECAPRO).

Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

BLOCKADE OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN PATIENTS WITH ARVD: A DOUBLE-BLIND MULTICENTRE PROSPECTIVE RANDOMIZED STUDY BRAVE

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Systemic Neoadjuvant and adjuvant Control by Precision medicine in rectal cancer (SYNCOPE) – approach on high-risk group to reduce metastases

Finland

Therapeutic use (Phase IV) EU CTIS Study details

Syncope trials by city

Syncope in Toronto Syncope in Vancouver Syncope in Montreal Syncope in Calgary Syncope in Edmonton Syncope in Ottawa Syncope in Winnipeg Syncope in Quebec City Syncope in Hamilton Syncope in Kitchener Syncope in London Syncope in Halifax Syncope in New York Syncope in Los Angeles Syncope in Chicago Syncope in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease